Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ocul Immunol Inflamm ; 29(6): 1072-1079, 2021 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-32077774

RESUMEN

Purpose: Placoid-pigment-epitheliopathies like Acute-Posterior-Multifocal-Placoid-Pigment Epitheliopathy (APMPPE) and Relentless-Placoid-Choroidopathy (RPC) usually show bilateral involvement. This retrospective case series describes the clinical features with unilateral disease onset.Methods: 21 patients from 9 tertiary referring institutions were collected and evaluated.Results: Seventeen patients were included: 11 (65%) had unilateral placoid-pigment-epitheliopathy consistent with APMPPE, 6 (35%) with RPC (mean age: 28.82 ± 9.1 years). Mean follow-up time was 45 ± 48 months. Forty-one percent fellow-eyes had initial inflammatory signs including vitreous-cells, vascular-sheathing, and ONH swelling. Thirty-five percent developed chorioretinal lesions during follow-up after 19.5 ± 16.9 months. Initial inflammation in fellow-eye was not associated with fellow-eye involvement (p = .5). However, subfoveal choroidal-thickness (SCT) at baseline was significantly thicker in fellow-eyes who developed chorioretinal lesion compared to fellow-eyes who did not (400 ± 70 µm versus 283 ± 127 µm,p = .047).Conclusion: Unaffected fellow-eyes may have inflammatory signs at initial disease-onset and may develop lesions over time. They should be carefully monitored, particularly if they present with an increased SCT.


Asunto(s)
Coroides/patología , Coroiditis/diagnóstico , Trastornos de la Visión/diagnóstico , Síndromes de Puntos Blancos/diagnóstico , Adolescente , Adulto , Azatioprina/uso terapéutico , Coroiditis/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores , Inflamación/diagnóstico , Inflamación/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Prednisona/uso terapéutico , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Trastornos de la Visión/tratamiento farmacológico , Agudeza Visual , Síndromes de Puntos Blancos/tratamiento farmacológico , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...